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Summary  
Disease progression in many tumor types involves interaction of genetically abnormal 
cancer cells with normal stromal cells. Neoplastic transformation in a Drosophila genetic 
model of EGFR-driven tumorigenesis similarly relies on the interaction between epithelial 
and mesenchymal cells, providing a simple system to investigate mechanisms used for the 
cross-talk. Using the Drosophila model, we show that the transformed epithelium hijacks 
the mesenchymal cells through Notch signaling, which prevents their differentiation and 
promotes proliferation. A key downstream target in the mesenchyme is Zfh1/ZEB. When 
Notch or zfh1 are depleted in the mesenchymal cells, tumor growth is compromised. The 
ligand Delta is highly up-regulated in the epithelial cells where it is found on long cellular 
processes. By using a live transcription assay in cultured cells and by depleting actin-rich 
processes in the tumor epithelium, we provide evidence that signaling can be mediated by 
cytonemes from Delta-expressing cells. We thus propose that high Notch activity in the 
unmodified mesenchymal cells is driven by ligands produced by the cancerous epithelial.  
This long range Notch signaling integrates the two tissues to promote tumorigenesis, by 




INTRODUCTION   
 
Cells in developing organisms are in continuous communication with their neighbors, with 
the signals sent and received being crucial for proper organ development. The careful 
regulation of these signals controls growth, coordination and homeostasis of complex 
tissues and organs.  In contrast, their aberrant regulation or inappropriate deployment is 
integral to many diseases including cancers. For example, signaling between genetically 
abnormal cells and the normal surrounding stromal cells supports tumor progression and 
malignancy, as in many carcinomas [1]. Although mutations driving cancer initiation, such 
as those causing hyperactivity of the EGFR/Ras signaling pathway, have been extensively 
characterized [2], it is important also to identify mechanisms that co-opt the surrounding 
stromal cells to sustain tumor growth. Normal tissue mesenchymal cells are thought to be 
“educated” within the tumor environment, acquiring properties that in turn enhance cancer 
cell proliferation and metastasis [3]. A better understanding of the plasticity, regulation and 
function of tumor mesenchymal cells is therefore important and could influence cancer 
treatments. 
Highly proliferative tumors arise from several genetic manipulations of Drosophila wing 
disc epithelial cells, for example through EGFR pathway hyperactivity in an epigenetically 
compromised context (EGFR-psqRNAi, [4]). These tumors grow as a large multilayer mass, 
mixing epithelial and mesenchymal cells, providing a simple model to investigate stromal 
interactions.  Although not directly modified, the mesenchymal cells are necessary for  
tumor growth, since ablating them genetically reduces tumor progression [4]. The 
mesenchymal cells arise from a pool of myogenic precursors, which normally give rise to 
tadult flight muscles and to a small number of undifferentiated satellite cells [5, 6]. 
Maintenance of these precursors under normal conditions requires Notch activity, which 
directs expression of several genes that help to sustain progenitor characteristics including 
Zfh1/ZEB [7, 8].  Indeed the ability of the satellite cells to escape differentiation involves 
upregulation of a short RNA isoform of zfh1, zfh1-short, that enables the cells to escape 
regulation by microRNAs [9].  ZEB has a similar function in mammalian precursors [10]. It 
is unclear however what roles, if any, Notch and/or zfh1 have in maintaining the tumor 
mesenchymal cells and in the cross-talk with the cancerous epithelium. 
A role for the evolutionarily conserved Notch pathway in regulating the tumor-promoting 
properties of mesenchymal cells is also suggested by its alterations in cancer-associated 
	 3	
fibroblasts in several tumor types [11, 12]. Whether Notch signaling could also be involved 
in the inter-tissue communication between the epithelium and mesenchyme has not, 
however, been explored. Notably, because the ligands are transmembrane proteins, Notch 
activation relies on direct cell-to-cell contacts. Interactions with the transmembrane, Delta–
Serrate-Lag (DSL), family of ligands provokes two cleavages of the Notch receptor to 
release its intracellular domain (Nicd). This moiety then translocates to the nucleus where 
it activates the transcription of target genes with its DNA binding-partner CSL [13]. Since 
the pathway activation relies on cell-to-cell contact, signaling commonly occurs between 
cells in the same tissue, for example within an epithelium.  However, longer range 
signaling has been found to occur in some circumstances through dynamic cellular 
process that can extend several cell diameters [14-16]. This raises the possibility that 
signaling could occur between different tissue types, such as between the tumor 
epithelium and adjacent stromal/mesenchymal cells.  
To determine whether Notch activity in unmodified mesenchymal cells contributes to tumor 
progression and whether the Notch pathway is involved in cross-talk with the aberrant 
epithelium, we investigated its role in EGFR-psqRNAi tumors [4, 17]. Importantly, this 
system utilizes an independent LexA targeted manipulation to assess gene functions 
specifically in the genetically normal mesenchyme, independent from any role in the 
cancer-driven epithelium [18].  We detect high levels of Notch activity in the tumor-
associated mesenchymal cells, where it is required to sustain tumorigenesis, preventing 
differentiation and promoting proliferation of the mesenchymal cells. Strikingly, the ligand 
Delta is highly up-regulated in the genetically altered epithelium, but not in the 
mesenchyme itself, and is present on long cellular processes. Results from live reporting 
of Notch pathway activation in cell culture and from perturbation of actin rich processes in 
the Delta-expressing epithelial cells suggest that signaling can occur at long range 
between the epithelium and neighboring mesenchyme through cell processes. The 
conserved transcription factor Zfh1/ZEB is an important direct target of signaling in the 
mesenchymal cells, being required to sustain tumor growth in a similar manner to Notch 
itself.  The contribution of the mesenchymal cells to tumor progression thus relies on Zfh1 






A large pool of myoblasts, located on the notal part of the wing disc (Figure 1A-B), are 
maintained as Twist-expressing undifferentiated precursors for a prolonged period, 
ultimately contributing to adult flight muscles during metamorphosis. Although not directly 
modified, these precursors, so-called mesenchymal cells, are necessary to sustain the 
growth of EGFR-psqRNAi tumors over many days [4]. These tumors ultimately consist of 
large multilayer masses, in which epithelial and mesenchymal cells become intermixed 
(Figure 1C-D) [4]. To investigate whether these mesenchymal cells indeed retain 
progenitor characteristics, we analyzed expression of differentiation genes (e.g. the 
muscle protein Tropomyosin) in advanced (8-day to 10-day) tumors. None of the 
differentiation markers were expressed, even in the most advanced stage tumors (Figure 
S1). Instead they exhibited high expression-levels of genes that prevent differentiation in 
normal myoblasts (e.g. Him, Figure S1A,E) [8, 19].  The ability of the mesenchymal cells to 
sustain tumor growth may therefore rely on them remaining undifferentiated. 
 
Mesenchymal Notch activity sustains tumor growth. 
Under normal conditions, Notch activity is important for preventing differentiation of the 
muscle progenitors [7, 20]. To evaluate Notch activity in EGFR-psqRNAi tumors, we first 
made use of a reporter containing an auto-regulatory enhancer from the Notch gene 
(Notch[NRE]-GFP; [21]) which is widely responsive to Notch activity including in the 
muscle progenitors (marked by Cut or Twist; Figure 1E-E’ and Figure S2 A-A’’). In EGFR-
psqRNAi tumors Notch[NRE]-GFP expression was robustly up-regulated throughout the 
mesenchymal cells (Figure 1F-F’’ and Figure S2 B-B’) indicating that Notch activity is 
maintained in these cells during tumor growth.  
Second we analyzed expression of m6-GFP, a Notch-responsive reporter that is 
expressed in a limited subdomain of the wild-type mesenchyme (Figure 1G-G’ and Figure 
S2C-C’’). The more restricted m6-GFP expression suggests that it requires higher levels of 
signaling than Notch[NRE]. In agreement, m6-GFP expression expanded through the 
mesenchyme when exogenous Notch activity was supplied there (Figure S2 C-D’’ and 
[22]). Thus the two reporters appear to respond to different levels of Notch activity and m6-
GFP marks the domain where levels of Notch activity are highest. In EGFR-psqRNAi tumors, 
m6-GFP expression was detectable in the majority of mesenchymal cells, based on 
analysis with two different mesenchymal markers (Cut, Figure 1G-I and Twist, Figure S2E-
	 5	
G), indicating they have high levels of Notch activity. As the expression levels were not 
uniform, it is likely that some mesenchymal cells have higher/lower levels of Notch activity 
than others. Nevertheless, m6-GFP was active in a large proportion of tumor 
mesenchymal cells (Figures 1I and S2G) and the endogenous transcript was significantly 
up-regulated (Figure S2H). Together these data indicate that there are high levels of Notch 
activity in the majority of mesenchymal cells in EGFR-psqRNAi wing discs. 
To test whether Notch activity in the mesenchyme is required to sustain tumor growth, we 
developed tools to manipulate gene expression in mesenchymal cells, independently of 
the epithelial cells, using the lexA system [23]. Thus, we generated a NotchRNAi transgene 
under lexA operator control (Figure S3A-D). We first confirmed functionality by directing 
expression in bristle cell precusors, where it produced extra bristles characteristic of 
reduced Notch activity (Figure S3E-F). Next, we used it to down-regulate Notch in the 
mesenchymal cells, using 15B03-lexA (Figure S3A-D), where it had a striking effect on the 
tumors, reducing their size to almost wild type dimensions (Figure 1J-M) although apico-
basal polarity was not fully restored. Thus high levels of Notch activity are necessary in the 
mesenchymal cells associated with EGFR-psqRNAi tumors to sustain their growth. These 
results emphasise the importance of tissue interactions in tumorigenesis and indicate an 
oncogenic role for Notch in the tissue that is not genetically modified.   
Tumorigenic epithelial cells deliver Delta ligand and activate Notch in the 
mesenchymal cells.   
Notch activity in the mesenchyme might arise from an increase in ligand expression in the 
myoblasts themselves, where Delta and Serrate are expressed under wild-type conditions 
[24, 25], or from inter-tissue signaling using elevated ligands in the adjacent EGFR-psqRNAi 
epithelial cells. The Notch protein itself is present in both the mesenchyme and the 
epithelial cells, in normal and tumor wing discs (Figure S4 A-B’). To investigate ligand 
expression, we tagged the endogenous Delta and Serrate genes with mScarlet 
(DeltamScarlet-I) and sfGFP (SerratesfGFP) respectively (Figure S4). Both ligands were 
expressed in the disc epithelium (Figure 2A-C and Figure S4E-E’’) but were almost 
undetectable in the myoblasts (e.g. Figure 2C). Within the epithelium, Delta was strikingly 
enriched in a group of epithelial cells closely adjacent to the m6-GFP expressing 
myoblasts (Figure 2C) whereas Serrate was detected at highest levels in nearby regions 
(Figure S4 E-E’’). As m6-GFP responds to high levels of Notch, the localized Delta 
expression could explain its restricted expression if Delta activates Notch in adjacent 
mesenchymal myoblasts. If the same model applies to the tumors, they should exhibit high 
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levels of Delta in the genetically altered epithelial cells. Indeed, when Delta expression 
was subsequently analyzed in EGFR-psqRNAi tumors, high levels were systematically 
detected in all epithelial cells (Figure 2D,G), whereas Serrate exhibited more variable 
expression (Figure S4F-G’’). The ubiquitous upregulation of Delta in the cancerous 
epithelium makes it a primary candidate to mediate Notch activation in tumor 
mesenchymal cells, although it is possible that Serrate also makes a contribution.  
In agreement with the model that signaling relies on epithelial Delta, its down-regulation in 
the genetically modified epithelium reduced the size of tumors (Figure S4H-J and S6B). 
Conversely, ectopic epithelial Delta expression was sufficient to induce m6-GFP 
expression in nearby myoblasts (Figure 2I-K) of otherwise normal discs. Ectopic m6-GFP 
was associated with all Delta clones where there were adjacent mesenchyme (11 Delta 
clones, n= 6 discs). These results support the hypothesis that, in the tumors, Notch is 
activated in the mesenchymal cells through Delta ligands provided by the aberrant 
epithelial cells.  
Mesenchymal Notch is activated via Delta-expressing epithelial cytonemes. 
As Delta is a transmembrane ligand, our model implies that epithelial cells are able to 
make cell-cell contacts with the mesenchymal cells. Indeed, these contacts would need to 
act across a range of several cell diameters, because the mesenchymal cells are often 
multilayered (e.g. Figure 2H) and they express m6-GFP even when located at a distance 
from the epithelial cells (Figure 2F), albeit at lower levels than the direct neighbours 
(Figure 2F). One possibility is that the epithelial cells extend long processes as suggested 
by a recent study, which detected cytonemes in EGFR-psqRNAi tumors [26]. To investigate, 
we combined membrane tagged GFP (mCD8-GFP) with EGFR-psqRNAi, so that any 
epithelial cell processes would be labeled with GFP, and analyzed the distribution of 
DeltamScarlet-I (Figure 3 and S5A).  Live-imaging of these tumors revealed arrays of cell 
processes  emanating from the basal side of epithelial cells (Figure 3A-B, S5A), many of 
which contained multiple DeltamScarlet-I puncta (Figure 3B’). We refer to these as cytonemes, 
in accordance with [26].  In fixed tissues, DeltamScarlet-I puncta were detected between 
Twist-expressing mesenchymal cells (Figure 3C-D’), often with an interdigitated 
distribution resembling a cell process, although GFP-labelled cytonemes can’t be 
visualized in fixed tissues [27]. As the Notch receptor is present in both populations (Figure 
S4A-B), we cannot distinguish whether there are reciprocal Notch containing processes 
emanating from the mesenchyme. However, it has been reported that cytonemes are also 
present on mesenchymal cells in these tumors [26]. 
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Our data suggest that Delta-expressing epithelial cytonemes might sustain high levels of 
Notch activity in the mesenchymal cells of tumors, as reported previously for signaling to 
air sac cells [15]. To investigate, we depleted Diaphanous (Dia), an actin binding protein 
essential for cytoneme development [15, 28], in the EGFR-psqRNAi epithelial cells and 
monitored effects on m6-GFP, as an indicator of Notch activity (Figure 3E-I). In agreement 
with a recent study [26], epithelial depletion of Dia significantly reduced the size of the 
EGFR-psqRNAi tumors (Figure 3 E and G). Importantly, m6-GFP expression in the 
mesenchymal cells was strongly decreased in comparison to control tumors (Figure 3F’,H’ 
and I). Altogether, these data provide evidance that Delta-expressing epithelial cells 
activate Notch in mesenchymal cells via cytonemes, to promote tumor development.   
Long range signaling by Delta-containing cytonemes has been reported in some contexts 
[15, 29], but what the real-time response from such small, and potentially transient, 
interactions might be is unclear. We therefore generated a cell culture system where we 
could visualize the transcriptional activity of a direct Notch target when exposed to Delta-
expressing cells.  To do so we utilized the MS2-MCP system, whereby nascent transcripts 
containing MS2 loops are detected by the recruitment of GFP-tagged MS2 binding protein, 
MCP-GFP [30].  We first inserted 24 MS2 stem-loops and the coding sequence of LacZ 
into the endogenous Notch-regulated E(spl)mβ gene [31], using CRISPR/Cas9 genome 
engineering in the context of a stable cell line expressing MCP-GFP (Figure 4A-B).  When 
Notch was activated using a chemical treatment, strong MCP-GFP puncta could be 
detected in the nuclei of these “Notch reporter cells” within 10-15 minutes (Figure S5B-D), 
in agreement with previous reports showing that E(spl) genes can be activated within this 
short timeframe [32].  
We then asked how rapidly these cells responded when added to a culture of Delta-
expressing cells [33]. Strikingly we could detect a clear response after 15-20 minutes 
despite the fact that, in many cases, the responding cells were only in contact with ligand-
expressing cells through fine processes (Figure4C-G and Video S1). No transcription 
occurred in isolated cells or in the absence of Delta cells. Thus, Notch is effectively and 
rapidly activated in the reporter cells despite that they are only interacting with ligand-
expressing cells through fine cellular processes, although further experiments would be 
required to prove unequivocally that these processes mediate contact-dependant signaling 
rather than exosomes or some mode of ligand presentation. Nevertheless these results 
harmonize with the model that cytonemes confer Delta activation from the epithelial cells 
to the mesenchyme in the tumors.  
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Notch activity promotes mitosis and prevents differentiation of mesenchymal cells.  
In EGFR-psqRNAi tumors, the mesenchymal and epithelial cells proliferate extensively. 
Indeed the proportions of cells containing phosphorylated histone H3 (PH3), indicative of 
cells undergoing mitosis, were similar between epithelial and mesenchymal tissues (Figure 
S6A and [4]). As Notch activity is important for proliferation and maintenance of the muscle 
precursors under normal conditions [7, 34, 35] we asked whether it performs a similar role 
in the tumor mesenchyme. First we analyzed the relative proportions of mitotic cells in 
domains with robust m6-GFP expression, indicative of high levels of Notch activity, 
compared to other regions (Figure 5A-C). A greater proportion of m6-GFP expressing cells 
in EGFR-psqRNAi tumors contained pH3 than non-expressing mesenchymal cells, 
signifying that Notch activity promotes cell division (Figure 5B,C). The percentages of 
mitotic cells were also much higher than in control discs (Figure 5A,C). Second, we 
depleted Notch in the mesenchymal cells. This resulted in a significant decrease in the 
number of mitotic cells as well as a reduction in cell numbers and tumor size (Figure 5D-G 
and Figure S6A). Notably, the tumors contained almost equal proportions of epithelial and 
mesenchymal cells wheres, when Notch was depleted in the mesenchyme, the relative 
size of the mesenchymal compartments was smaller and more similar in proportions to 
wild-type (Figure S6B). Together, these data support the idea that Notch activity 
contributes to the proliferation of mesenchymal cells, sustaining tumor progression.   
Second, we investigated whether Notch is required in the mesenchymal cells to prevent 
their differentiation. Normally, the muscle differentiation program is triggered by a decline 
in Notch activity and in the levels of its targets, Twist and Him, which allows Mef2 levels to 
increase [8, 19, 36]. EGFR-psqRNAi tumors have signatures of undifferentiated 
mesenchyme, with high levels of Him mRNA and low levels of Mef2, indicating that these 
cells are undifferentiated. (Figure S1). In contrast, when Notch was depleted in the 
mesenchyme, using RNAi, markers of muscle differentiation, such as Tropomyosin (Tm), 
were present in some mesenchymal cells (Figure S7A,B).  Thus Notch activity in the 
mesenchymal cells inhibits their differentiation, as well as fostering their proliferation, 
enabling their expansion in the EGFR-psqRNAi tumors.  
Given that Dpp activity in the mesenchyme is also required to sustain EGFR-psqRNAi 
tumors [4], we asked whether this was also dependent on Notch activity. However, there 
was no change in the levels of phosphorylated Mad (pMad), a measure of Dpp pathway 
activity, when Notch was depleted in the mesenchyme of EGFR-psqRNAi tumors (Figure 
S6C-D). Likewise, when Mad was depleted from the mesenchyme of tumors, epithelial 
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Delta expression remained high, similar to control tumors (Figure S6E-F). Together these 
data indicate that the effect of Notch on mesenchymal cells differentiation is not via Dpp 
signaling but rather the two pathways are acting in parallel to regulate tumor growth. 
 
Zfh1/ZEB acts downstream of Notch and promotes tumor growth.   
The transcription factor Zfh1/ZEB is required for maintaining the myogenic progenitors and 
is directly regulated by Notch activity [9, 37]. As a first step to test whether Zfh1 expression 
contributes to Notch regulated expansion in tumors, we analyzed expression from the zfh1 
Notch responsive enhancer (Enh3-GFP).  Robust Enh3-GFP expression was present 
throughout the majority of mesenchymal cells in the tumors (Figure 6A-B). In contrast, a 
mutated version, Enh3[mut]-GFP, lacking the Notch responsive motifs [9] exhibited very 
little, if any, expression in tumors of a similar age (Figure 6D-E’). Furthermore, there was a 
significant increase in the levels of both zfh1 mRNA isoforms in tumors, compared to wild 
type (Figure S7).  In situ hybridization and analysis of  zfh1-short-GFP expression, 
confirmed that zfh1-short, the isoform implicated in maintaining progenitor status [9], was 
significantly upregulated (Figure S7). These data demonstrate that zfh1 mRNAs, including 
zfh1-short, are highly expressed in the tumors and suggest that this occurs by direct Notch 
regulation via Enh3.  
Given that zfh1 levels were elevated in the mesenchymal cells, we sought to address the 
role of Zfh1 in tumor development. We generated strains to express zfh1RNAi under the 
control of lexAop, so that zfh1 expression could be specifically depleted in the 
mesenchymal cells using the 15B03-LexA driver (Figure 6F-I). Down-regulating zfh1 in 
myoblasts proved sufficient to significantly reduce tumor growth (Figure 6I and Figure 
S6B) and induced the premature differentiation of mesenchymal cells (Figure S7C). 
Similar to Notch depletion, the apico-basal organization was however not fully restored 
(Figure 6F-H). Nevertheless, the reduction in tumor size caused by zfh1 depletion argues 
that zfh1 has an important functional role in the mesenchymal cells to promote tumor 




Normal tissue mesenchymal cells are thought to have important roles in promoting the 
growth and metastasis of many tumors. To do so they must be educated by the aberrant 
cancerous cells to acquire the properties needed to sustain tumorigenesis. Using a 
Drosophila model of EGFR/Ras-driven tumorigenesis [4, 17] we demonstrate that Notch 
activity in the unmodified mesenchymal cells is essential for tumor growth. Down-
regulating Notch specifically in mesenchymal cells reduced their proliferation rates, 
promoted their differentiation and significantly compromised the size of tumors that 
developed. Strikingly, the activation of Notch in these supporting cells appears to rely on 
direct communication from the cancerous epithelial cells, illustrating that this pathway can 
operate in long-range signaling between tissue layers (Figure 7).  
The conclusion that Notch receptors in the mesenchymal cells are activated from ligands 
presented by nearby epithelial cells is unexpected, because most examples of Notch 
signaling occur between cells within an epithelial cell layer. The fact that the ligands are 
transmembrane proteins means that direct cell-cell contacts are required to elicit signaling, 
and that signaling usually occurs between neighboring cells.  More recently, examples 
have emerged where signaling occurs across longer distances that appear to involve 
contacts mediated by cell protusions, such as filopodia or cytonemes [14-16]. Our 
evidence indicates that a similar mechanism operates in tumors. Delta is produced in the 
epithelial cells and can be detected in fine processes that extend through the nearby 
mesenchymal cells, consistent with a recent report describing cytonemes in these EGFR-
psqRNAi tumors [26]. In a heterologous system, we found there was robust activation of a 
Notch target gene rapidly after ligand expressing cells made contact through cell 
processes. Likewise, ectopic patches of Delta in the disc epithelium led to expression of 
the Notch-regulated m6-GFP in the underlying mesenchyme. Thus we propose that the 
widespread upregulation of Delta in the epithelial compartment of the tumorous wing discs 
in turn activates the Notch pathway in the neighbouring mesenchymal cells via long 
cellular processes. As a consequence, the mesenchymal cells become coordinated with 
the cancer epithelial cells and are maintained in an undifferentiated state (Figure 7).  
While our data demonstrate that Delta-Notch mediated inter-tissue signaling is important 
for sustaining tumor growth, it is evident that other signals are also required. First, it was 
previously shown that Dpp from the cancerous epithelium is essential for these tumors to 
grow [4]. Since the Dpp pathway was still activated in the mesenchyme when Notch was 
depleted, we propose that Dpp and Notch operate in parallel. This may explain why 
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apicobasal polarity was not fully restored when Notch activity was impaired and highlights 
the likelihood that several different pathways are coopted to drive tumorigenesis. Second, 
the fact that tumorigenesis is rescued by perturbing Notch (Figure 1) or Dpp signaling [4] in 
the mesenchyme, argues that there must be a reciprocal signal to the epithelium. Notably, 
the relative growth of the two populations appears highly co-ordinated in the tumors 
(Figure S6B) unlike wild-type where the epithelial growth predominates. A plausible model 
is that combined inputs from Notch and Dpp are required to produce reciprocal signal(s) 
and it will be interesting to discover whether the reciprocal signaling also operates through 
cytonemes, given that the mesenchymal cells emit processes [26]. 
One of the key effectors of Notch activity in the tumor mesenchyme is Zfh1/ZEB, which is 
important for maintaining the muscle progenitors in normal conditions. In a similar manner, 
its expression is kept high in the tumor mesenchyme, due to Notch activity, where it helps 
prevent their differentiation. Down-regulating zfh1 in mesenchymal cells induces their 
premature differentiation and prevents tumors growth. The role of Zfh1/ZEB in promoting 
progenitors and stem cell proliferation appears to be widespread [10]. Furthermore, ZEB1 
is upregulated in many cancers, where it can cause the expansion of cancer stem cells 
and frequently drives epithelial to mesechymal transition to promote metastasis [38, 39]. 
Whether its activation in these conditions also involves Notch activation and inter-tissue 
signaling remains to be determined.  
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Main figure titles and legends  
 
Figure 1.  Requirement for Notch activity in tumor mesenchyme. (A-B) Apterous-Gal4 
(Green, ap-Gal4>UAS-mCD8::GFP) drives expression in epithelial cells but not myoblasts 
(Twist, Magenta). (B) Optical cross-sections of A demonstrate that the epithelium (E) and 
myoblasts (M) form separate tissue-layers.  (C-D) Tumors induced by expression of EGFR 
and psqRNAi (ap-Gal4>UAS-EGFR;UAS-psqRNAi) co-expressing mCD8::GFP, 8 days after 
induction; epithelial (Green) and mesenchymal cells (Magenta) become intermingled. (C’) 
Higher magnification (6x) of boxed region in C.  (D) Optical cross-sections of C’. (E-F) 
Expression of Notch[NRE]-GFP reporter (Green) in wild type myoblasts (E-E’: Cut, 
Magenta) and in mesenchyme of ap>EGFR-psqRNAi tumors (F-F’’). DE-Cadherin (DE-Cad), 
blue, marks epithelial cells. (G-H’) Expression of m6-GFP reporter (green) is detected in a 
small group of myoblasts (Cut, Magenta) in wild type (G-G’) but is widely upregulated 
throughout the mesenchyme (Cut, Magenta) in ap>EGFR-psqRNAi tumors (H-H’’’). DE-Cad, 
blue, marks epithelial cells. G’ and H’’’ are optical cross-sections. (I) Proportion of 
myoblasts expressing m6-GFP in the indicated genotypes (****p<0.0001, unpaired t-test; 
n=18 wild type, n=22 tumorous wing discs; light, dark and intermediate shading indicates 
data points from three independent replicates). (J-L) Depletion of Notch in mesenchymal 
cells reduces tumor size. (J) Wild-type disc, (K) ap>EGFR-psqRNAi tumor (L) ap>EGFR-
psqRNAi tumor after mesenchymal Notch depletion with 15B03-lexA; LexAop-NotchRNAi. 
DE-Cad (green) marks epithelial cells and Cut (magenta) marks the 
myoblasts/mesenchyme. (M) Volumes in the indicated genotypes (****p<0.0001; Mann–
Whitney U test, n=27 wing discs from each genotype; light, dark and intermediate shading 
indicates data points from three independent replicates). Scale bars represent 100µm. See 
also Figure S1, S2,S3 and Table S1.  
 
Figure 2. Tumorigenic epithelial cells provide Delta to activate Notch in nearby 
mesenchymal cells. (A-C) Delta is enriched in a patch of epithelial cells adjacent to m6-
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GFP expressing myoblasts; normal wing disc with Delta (DeltamScarlet-I, Magenta) and m6-
GFP (Green) expression in notal region, Twist, (blue) marks myoblasts. (D-F) In 
ap>EGFR-psqRNAi tumors, high levels of Delta (Delta, magenta) are detected in epithelial 
cells but not mesenchyme (Twist, Blue), where m6-GFP is up-regulated (GFP, green).  (E-
F) Individual channels of boxed region in D. m6-GFP expression is elevated in 
mesenchymal cells adjacent to the epithelial cell layers. (G-G’) Apical confocal plan of 
ap>EGFR-psqRNAi tumors expressing DeltamScarlet-I, Twist (Green) marks mesenchyme. 
(G’) Higher magnification (10x) of boxed region in G. (H) Sagittal section of G’ 
demonstrates multi-layering of mesenchymal cells which reduces proportions making 
direct cell contact with epithelial cells (asterisks). (I-K) Over-expression of Delta in 
epithelial clones (marked by RFP, magenta) leads to ectopic m6-GFP (GFP, Green) in 
adjacent mesenchyme (arrow; other small patches of Delta/RFP lack any adjacent 
mesenchyme). Rectanglular boxes (I) contain XZ and YZ sections in the planes indicated 
by the dashed axes. Dotted lines indicates the morphological boundary separating 
epithelium and mesenchyme. J-K) Higher magnification (25x) of sections in (I) 
corresponding to the region indicated by the intersection of the dashed axes, with 
epithelial (E) mesenchyme (M) layers. Scale bars represent 50µm. See also Figure S4 and 
Table S1. 
Figure 3. Epithelial cells signal via cytonemes to activate Notch in the mesenchymal 
cells. (A-B’) Long cell processes, cytonemes, (mCD8::GFP, Green), extend from the 
basal side of epithelial cells in ap>EGFR-psqRNAi tumors. Scale bars: 10µm. (B’) Higher 
magnification of boxed region in B, Delta (DeltamScarlet-I, Magenta) puncta can be detected 
along the cytonemes. Scale bar: 5µm.  (C-D’) Delta puncta (DeltamScarlet-I, magenta) are 
detected along the boundary between mesenchymal cells (Twist, green) in ap>EGFR-
psqRNAi tumors, DAPI (blue) marks all nuclei. (D-D’) Higher magnification of boxed region 
in C: DeltamScarlet-I puncta are in close association with mesenchyme (arrowheads in D’). 
Scale bars represent 10µm. (E-I) Impairement of epithelial cytonemes, via Dia depletion 
(G-H), prevents tumor growth and reduces mesenchymal Notch activity (m6-GFP, Green; 
Cut, Magenta). DAPI (blue) marks all nuclei. (E-F’) High levels of m6-GFP (Green) in 
mesenchyme of ap> EGFR-psqRNAi tumors; (F-F’) higher magnification of boxed region in 
E. (G-H’) Ablating cytonemes by expressing DiaRNAi in epithelial cells reduces m6-GFP in 
the mesenchyme; (H-H’) higher magnification of boxed region in G.   (I) Proportions of 
myoblasts expressing m6-GFP in the indicated genotypes (**** p<0.0001; Mann–Whitney 
U test, n=21 EGFR-psqRNAi (Control), n=20 EGFR-psqRNAi + diaRNAi. Light, dark and 
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intermediate shading indicates data points from three independent replicates). See also 
Figure S5 and Table S1.   
 
Figure 4. Live imaging of transcriptional response to ligand-expressing cells. (A-B) 
Scheme illustrating strategy for MS2 tagging of E(spl)mβ-HLH gene. (A) Modified 
E(spl)mβ transcripts contain MS2 stem-loops (mβ-MS2) which are bound by the MCP-
GFP, producing nuclear puncta when E(spl)mβ is active. (B) Schematic for genome 
editing of E(spl)mβ with CRISPR/Cas9 to insert 24 MS2 stem-loops (MS2SL) and lacZ 
coding sequences along with a blasticidin resistance cassette (BlastR) flanked by FRT 
sites. Similar results were obtained with and without removal of BlastR. (C) Cellular 
projections emanate from both S2-Delta (α-Delta, Magenta) and mβ-MS2 cells (GFP, 
Green, arrows). (D-F) Time course (mins) demonstrating that transcription foci (MCP 
puncta, white) are detected in nuclei of mβ-MS2 cells 15-20 minutes after mixing with S2-
Delta cells, when cellular process are seen extending between the cells (arrows in D; note 
S2-Delta cells do not express any Notch receptor). (E) Individual track of the maximum 
mβ-MS2 transcriptional fluorescence intensity of the cell nucleus indicated in D. (F) Time 
course with mean maximum fluorescence for all responding mβ-MS2 nuclei following 
exposure to S2-Delta cells, (error bars indicate s.e.m, n=16). (G) No transcriptional 
response was detected in experiments where mβ-MS2 cells were incubated without S2-Dl 
cells. See also Figure S5, Video S1 and Table S1.  
Figure 5. High Notch activity in the mesenchymal tumor cells sustains their 
proliferation. (A-B’’) Mitotic cells (anti-PH3, blue) in wild type (A) and ap>EGFR-psqRNAi 
tumors (B) samples, Twist (magenta) marks all mesenchymal cells and m6-GFP (green) 
indicates Notch activity. Insets in B’-B’’ are enlarged views (2X) of framed regions in B. 
Scale bars, 100µm. (C) Ratio of m6-GFP positive or negative myoblasts that have PH3 
(****p<0.0001, unpaired t-test, light, dark shading indicates data points from two 
independent replicates). (D-G) Notch activity is required for mesenchymal-cell proliferation. 
Wild type discs (D), ap>EGFR-psqRNAi tumors (E) and ap>EGFR-psqRNAi tumors in which 
mesenchymal Notch is depleted using 15B03-lexA; LexAop-NotchRNAi (F) stained with anti-
Twist (Magenta), anti-PH3 (Green) and DAPI (Blue). (G) Quantification of myoblast mitotic 
index in the conditions shown in D,E and F***, p<0.0001 (Mann–Whitney U test). Light, 
dark shading indicates data points from two independent replicates. Scale bars: 100µm. 
See also Figure S6 and Table S1. 
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Figure 6. Zfh1/ZEB is directly regulated by Notch and is required in tumor 
mesenchyme. (A-B) Expression of Enh3-GFP in wild type (A) and ap>EGFR-psqRNAi (B) 
discs, where its expression is greatly expanded through the mesenchyme (Cut, Magenta). 
(C) Proportion of myoblasts/mesenchyme expressing Enh3-GFP in the indicated 
genotypes (****p<0.0001, unpaired t-test, n=15 wild type and 18 EGFR-psqRNAi wing discs, 
light and dark shading indicates data points from two independent replicates). Scale bars: 
100µm. (D-E’) Enh3 expression (D, Enh3-GFP, Green) in mesenchymal cells (Twist, 
Magenta) is abolished when Su(H) motifs are mutated (E, Enh3[mut]-GFP, Green). Scale 
bars: 50 µm. (F-I) Down regulation of zfh1 in mesenchymal cells reduces tumor growth. 
Wild type (F), ap>EGFR-psqRNAi tumor (G) and ap>EGFR-psqRNAi tumor where zfh1 is 
depleted with 15B03-lexA; LexAop-zfh1RNAi (H); DE-Cad (green) marks epithelial cells Cut, 
(Magenta) marks mesenchyme and DAPI (Blue) labels all nuclei. (I) Tumor volume in the 
indicated genotypes (****p<0.0001, Mann–Whitney U test; light, dark and intermediate 
shading indicates data points from three independent replicates). Scale bars: 100 µm. See 
also Figure S7 and Table S1. 
Figure 7. Model summarizing the role of Notch in mediating the tumor-stroma 
interactions. In EGFR-psqRNAi tumors, the tumorogenic epithelial cells contain high levels 
of Delta (Red) which activates Notch in the unmodified mesenchymal cells. Delta is 
present on epithelial cell membranes and on long cellular processes, allowing signaling to 
occur over longer ranges. By activating Notch, epithelial cells hijack the mesenchymal 
cells, preventing their differentiation and promoting proliferation so that tumorigenesis is 
sustained.   
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LEAD CONTACT AND MATERIALS AVAILABILITY 
Further information and requests for resources and reagents should be directed to, and 
will be fulfilled by, the Lead Contact, Sarah J Bray (sjb32@hermes.cam.ac.uk).   
All strains, plasmids, and reagents generated in this study are available from the Lead 





EXPERIMENTAL MODEL AND SUBJECT DETAILS  
Drosophila melanogater strains and genetics  
All Drosophila melanogaster stocks were grown on standard medium at 25°C. The 
following stains were used: The EGFR-psqRNAi and 15B03-lexA lines were provided by 
Hector Herranz [4], w118 as wild type (wt), UAS-white-RNAi as control for RNAi 
experiments (BL#35573), Ap-Gal4 (BL#25685), UAS-mCD8-GFP (BL#5137), Notch[NRE]-
GFP [21], m6-GFP [22], UAS-Delta30B [40], Enh3-GFP and Enh3[mut]-GFP [9], Him-GFP 
[41], CG9650-YFP (CPTI#1741), MHC-lacZ [42], UAS-Notch∆ECD [43-45], LexAop-CD8-
GFP (BL#66545), Ptc-LexA (BL#54926), UAS-DlRNAi (BL#28032), UAS-DiaRNAi 
(BL#33424), LexAop-MadRNAi [4]. The EGFR-psqRNAi tumors were inducted as described in 
[4]. The flip out clones were generated using hs-flp;Actin5c>CD2>GAL4,UAS-RFP 
(BL#30558). The progeny obtained from the Flip out>RFP X UAS-Delta; m6-GFP crosses 
were heat-shocked 1h at 37°C at late second instar larva stages and analyzed as 
described in the Figure 2I. See Table S1 for full genotypes of samples analyzed. 
Generation of fly and cell lines  
LexAop-NotchRNAi and LexAop-Zfh1RNAi  
Inverted repeat fragments targeting either Notch or Zfh1 were amplified using yw genomic 
DNA as template and inserted into the pJFRC19 plasmid [23] at NotI and XbaI sites (Table 
S2). Both resulting constructs were inserted into an AttP site located at 68A4 on 
chromosome III by injection into nos-phiC31-NLS; attP2 embryos. Knock down efficiency 
for NotchRNAi was verified by driving the RNAi with Ptc-LexA and assessing the scutellar 
bristles phenotype (Figure S3E-F) and for LexAop-Zfh1RNAi by assessing premature 
differentiation of the myoblasts with 15B03-LexA (Figure S6C).  
 
DlmScarlet-I, SersfGFP and Zfh1-ShortsfGFP  
Lines were generated by CRISPR-mediated homology repair (HR) strategy. For 
DeltamScarlet-I, mScarlet-I DNA fragment was inserted at the KGAS//GGPG position, as 
previously described in [46]. The homology arms were cloned into a modified donor 
template plasmid pScarlessHD-sfGFP-DsRed (Addgene #80811), where the sfGFP was 
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replaced by mScarlet-I [47] using Gibson assembly strategy. SerratesfGFP was generated 
by inserting sfGFP at the PPS//SGD position. The homology arms were cloned into the 
donor template plasmid pScarlessHD-sfGFP-DsRed (Addgene #80811) using Gibson 
assembly. A Similar strategy was used to generate Zfh1ShortsfGFP, where a sfGFP was 
inserted at the 3’ end of the first zfh1-RA exon. The guides RNAs were cloned into the 
guide RNA expression vector pCFD3 vector (Addgene #49410) [48].	The guide RNA and 
the donor template constructs specific for each line were injected into nos-Cas9 (BL54591) 
embryos. Flies with insertions were identified by the expression of the Ds-Red in the eyes 
and verified by genomic PCR sequencing. The transposable element containing the 
DsRed was removed subsequently using the PiggyBac Transposase system.   
Generation of the mβ-MS2 cell line 
A cell line expressing MCP-GFP constitutively was first created by transfecting Kc167 cells 
(DGRC) with an MCP-GFP plasmid, generated by cloning MCP-GFP (from pMS2-GFP, 
Addgene #27121) [49] into the Ac5-STABLE2-neo plasmid (Addgene #32426) [50] at XbaI 
and HindIII sites. A single clone was subsequently isolated and amplified from the 
transfected cells, to ensure relatively uniforms levels of MCP-GFP expression. DNA 
encoding MS2 stem-loops was inserted into the into the E(spl)-mβ-HLH gene (Figure 4) of 
the MCP-GFP cells, by CRISPR gene editing. The guide RNA expression vector was 
generated by inserting specific E(spl)-mβ-HLH oligonucleotides (Table S2) into the pCFD3 
plasmid (Addgene #49410) at BbsI site.  For homology directed repair, a fragment carrying 
two homology arms (HR), the MS2 stem-loops and a 3-kilobase region of the lacZ gene 
was inserted into plasmid pMH3 (Addgene #52528) [51] (Figure 4). The CRISPR mixture 
containing the gRNA, HR-MS2-LacZ and pAct-Cas9 (Addgene #62209) [48] plasmids was 
transfected into MCP-GFP cells. The resulting mβ-MS2 cells were selected by their 
resistance to the Blasticidin antibiotic and genotyped by sequencing of the modified 
genomic fragments. The blasticidin resistance cassette was removed by flippase-induced 
recombination induced with the pMH5 plasmid (Addgene #52531) [51].   
 
METHOD DETAILS 
Immunostainings and in situ hybridization  
The following primary antibodies were used for Immunofluorescence staining: Goat anti-
GFP (1:200, Abcam, ab6673), Mouse anti-Cut (1:20, DSHB), Rat anti-DE-Cad2 (1:200, 
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DSHB), Mouse anti-Delta (1:50, DSHB), Mouse anti-β-Gal (1:1000, Promega, Z378A), Rat 
anti-Tropomyosin (1:1000, Abcam, ab50567), Rabbit anti-Zfh1 (1:5000, a gift from Ruth 
Lehmann, New York, USA), Rabbit anti-Mef2 (1:200) and Rabbit anti-Twist (1:2000) (Gifts 
from Eileen Furlong, Heidelberg, Germany), Mouse anti-pH3 (1:100, Cell Signaling 
Technology, #9706), Mouse Anti-NICD (1:100, DSHB).	 In situ experiments were carried 
out according to Stellaris-protocols and as described in [9]. 	
Quantitative RT PCR  
30 to 40 Wing discs from each condition were dissected and RNA isolated using TRIzol 
(Life technologies). RNA was reverse transcribed using M-MLV reverse transcriptase 
(Promega M531A). Quantitative PCR was performed using LightCycler 480 SYBR Green I 
Master PCR kit (Roche 04707516001). Three independent biological replicates were 
analyzed for each condition. Values were normalized to the level of Rpl32 or Twi (Table 
S2). 
Cell culture experiments and imaging     
In control experiments, Notch was activated by treating the cells with 4mM EGTA as 
described [52]. For co-culture experiments, around 2 million S2-Dl cells (which express 
Delta under the control of a metallothionein promoter, DGRC #152; [33] were first plated in 
a cell culture dish previously treated with 0.01% poly-L-lysine. Delta expression was 
induced with media containing 5mM of copper sulphate 24 hours before imaging. The 
Delta induction media was replaced by 1 million mβ-MS2 cells. The cell imaging was 
performed with a Leica TCS SP8 confocal microscope; the transmitted light was used 
alongside the GFP fluorescence to visualise the S2-Dl cells, distinguished from the GFP-
expressing mβ-MS2 cells.  
QUANTIFICATION AND STATISTICAL ANALYSIS  
Image and statistical analysis  
Samples were imaged with TCS SP8 microscopes (CAIC, University of Cambridge) at 20X 
or 40X magnification and 1024/1024 pixel resolutions. Live imaging experiments of the 
wing discs were performed as described in [53]. Image J software was used to analyze 
images and measure reporter expression area [54]. For experiments to compare and 
measure the reporter expression area, samples were prepared and analyzed in parallel, 
with identical conditions and the same laser parameters used for image acquisition. For 
	 19	
each confocal stack a similar Sum slices projections was generated using Image J 
software. The percentage of cells expressing the reporter was obtained by calculating 
(automatically) for each sample the total myoblasts area (based on myoblasts Twist or Cut 
markers), and the area of the GFP expression. Tissues volume (in µm3) were measured 
using Volocity 3D Image analysis software (PerkinElmer). The mitotic index was calculated 
by dividing the total number of Myoblasts (Twist +) by the number of the cells undergoing 
mitosis (PH3 +). Statistics were calculated with GraphPad Prism and, depending on the 
Gaussian distribution of the values, either the unpaired t test or the Mann–Whitney non-
parametric test was used as indicated in the legends.  
MS2 computational analysis 
Maximum projections of the videos were made using Fiji software and cells were 
segmented and tracked over the time with a  MATLAB script (available 
at https://github.com/juliafs93/MS2_cells). Briefly, cells were segmented from the MCP-
GFP signal using a combination of median filtering and identification of circular shapes 
using the “imfindcircles” function. Cells were tracked over the time by finding the closest 
neighbour in a 15-pixel radius and allowing search in the previous 5 frames. Tracks 
containing fewer than 360 frames (~1 hour) were removed from the analysis. Tracked cells 
were overlaid with the MCP-GFP signal to obtain the maximum intensity pixel for each 
nucleus, which was used as a proxy of the transcriptional spot fluorescence. This analysis 
provided values of maximum fluorescence for each tracked cell over time. Final 
fluorescent traces were obtained by applying a moving average of 5 frames and 
background was removed using a regression line calculated using the lower quartile of 
values for each cell. All traces from active cells were manually curated and in co-culture 
experiments t=0 was set when each mβ-MS2 cells contacted the plate.   
DATA AND CODE AVAILABILITY 
The MATLAB scripts for tracking and analysing mβ-MS2 transcription are availble 
at https://github.com/juliafs93/MS2_cells.  
 
Video S1.  Notch pathway is activated rapidly through long cellular processes. 
Related to Figure 4. Live imaging of E(spl)mβ-MS2 (mβ-MS2) cells co-cultured with 
Delta-expressing S2 cells (S2-Dl). The mβ-MS2 and S2-Dl cells make contact through 
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Figure S1. Tumor mesenchymal cells are maintained undifferentiated. Related to 
Figure 1.   
(A-D’) ap > EGFR-psqRNAi wing discs dissected 8-10 days after Gal4 induction stained for 
the following progenitor and differentiation markers. (A-A’) Him-GFP (Green) and Twist 
(Magenta). (B-B’) CG9650-YFP (Magenta) and Mef2 (Green). (C-C’) MHC-LacZ (Green) 
and Cut (Magenta). (D-D’) Tropomyosin (Green) and Cut (Magenta). The genotypes are 
indicated above each panel. Scale bars: 100µm. (E) Twist, Him and Mef2 mRNA 
expression levels measured by quantitative RT-PCR. RNAs were prepared from three 
independent experiments. Error bars represent s.e.m.  
	

Figure S2. Notch activity is up regulated in the mesenchymal cells during tumor 
growth. Related to Figure 1.   
(A-B’) Expression of Notch[NRE]-GFP reporter (Green) and myoblast marker Twist 
(Magenta) in wild type myoblasts (A-A’’) and in mesenchyme of ap> EGFR-psqRNAi tumors 
(B-B’). (A’-A’’) Higher magnifications of the boxed region in A. (C-D’) Expression of an 
activated Notch (D-D”; 1151-Gal4>UAS-N∆ECD) induces ectopic m6-GFP (GFP, Green) 
in the myoblasts (Cut, Magenta) in comparison with wild type (C-C’’’). (E-F) Expression of 
m6-GFP reporter (green) is detected in a small group of myoblasts (Twist, Magenta) in 
wild  type (E-E’’) but is widely upregulated throughout the mesenchyme (Twist, Magenta) 
in ap>EGFR-psqRNAi tumors (F-F’). (G) Proportions of myoblasts expressing m6-GFP in 
the indicated genotypes (****p<0.0001, Mann–Whitney U test, n=18 wild type, n=19 
tumorous wing discs, light and dark shading indicates data points from two independent 
replicates). (H) m6 mRNA expression level measured by quantitative RT-PCR. RNAs were 
prepared from wild type wing discs or ap>EGFR-psqRNAi tumors obtained from three 
independent experiments. *p<0.05, unpaired Student’s t-test comparing wild type and 
tumorous wing discs. Error bars represent s.e.m. 
	

Figure S3. 15B03-lexA driver is expressed in wild type and tumorous wing disc 
myoblasts. Related to Figure 1.  
(A-D’’) Expression of 15B03-LexA driver (detetced with GFP, Green) in wild type (A,C) 
and tumorous (B,D) wing discs. Myoblasts (Magenta) are marked with Cut (A-B’’) or Twist 
(C-D’’). B’ and D’ are higher magnifications of boxed regions in B and D, respectivelly. 
Scale bars: 50µm. (E-F) Increased numbers of scutellar bristles were observed when 
expression of LexAop-NotchRNAi was driven with patched-LexA.  
	

Figure S4. Expression of Notch, DeltamScarlet-I and SerratesfGFP in wild type and 
tumorous discs. Related to Figures 2. 
(A-B’) Distribution of Notch (anti-NICD, Green) in wild type wing discs (A-A’’) and ap> 
EGFR-psqRNAi tumors (B-B’). Twist marks myblasts (Magenta). (A’’’) Optical cross-
sections of wild type. (C-D’’) Comparison of Delta (Green) and DeltamScarlet-I (Magenta) 
expression in eye (C-C’’) and wing discs (D-D’’); DeltamScarlet-I reliably reproduces the 
expression pattern of Delta. (E-E’’) Comparison of Delta (DeltamScarlet-I, Magenta) and 
Serrate  (SerratesfGFP, Green) expression in wing disc epithelial cells (notum); low levels of 
Serrate are detected in the region with high levels of Delta (arrows in E’, E’’). Scale bars: 
50µm. (F-F’’) SerratesfGFP (Green) exhibits variable expression in ap>EGFR-psqRNAi 
epithelial cells (DE-Cad, Magenta; arrows in F’, F’’). F’-F’’ are individual channels of 
framed region in F. (G-G’’) SerratesfGFP (Green) is not detected the mesenchymal cells 
(Twist, Magenta). G’ and G’’ are individual channels of framed region in G. Genotypes are 
indicated in the figure. (H-J) Epithelial Delta expression is required for tumor-growth. Wild-
type (H), ap>EGFR-psqRNAi; UAS-whiteRNAi (I) and ap> EGFR-psqRNAi; UAS-DeltaRNAi (J) 




Figure S5. E(spl)mβ-HLH transcription is detected within short timeframe after 
Notch activation. Related to Figures 3 and 4. 
(A) Lower magnification image of the sample shown in Figure 3A-B’, a maximum Z-stack 
projection illustrates both apical and basal views. Scale bar: 20µm. (B) mβ-MS2 cells at 
the time points indicated after Notch activation by EGTA treatment. Transcriptional foci are 
detected 10-15 minutes after Notch activation. (C) Mean of maximum E(spl)mβ-HLH 
transcriptional fluorescence from responding cells, error-bars indicate s.e.m. E(spl)mβ-
HLH transcription is upregulated and subsequently down-regulated over a period of 
approximately 60 minutes. (D) Transcriptional spots are not detected under control 
conditions (treatment with PBS only).  
	

Figure S6. Notch and Dpp pathways operate in parallel to promote tumor growth. 
Related to Figure 5.   
(A) Proportion of dividing mesenchymal (Magenta) and epithelial cells (Green) in 
ap>EGFR-psqRNAi tumors (n=24 samples from two replicates) and ap>EGFR-psqRNAi 
tumors where mesenchymal Notch is depleted (15B03-lexA; LexAop-NotchRNAi; n=30 
samples from two replicates). (B) Comparison of epithelial and mesenchymal volumes in 
the indicated genotypes. Wild type, ****p<0.0001; >NotchRNAi, ****p<0.0001; >DeltaRNAi, 
***p=0.0002; >Zfh1RNAi, **p=0.01 (unpaired t-test). (C-D) Depleting Notch in the 
mesenchymal cells does not affect p-Mad expression (Magenta). (E-F’). Depleting Mad in 
the mesenchymal cells (Twist, Green) does not affect levels of Delta (Magenta) in the 
epithelium. Genotypes are indicated in the figure. Scale bars: 50µm. 
	

Figure S7. Notch and zfh1 are required to prevent differentiation of mesenchymal 
cells in ap>EGFR-psqRNAi tumors. Related to Figure 6. 
(A) In unmanipulated ap>EGFR-psqRNAi tumors, mesenchymal cells (Cut, Magenta) do not 
express Tropomyosin (Green). ap>EGFR-psqRNAi tumors where Notch (B) or zfh1 (C) 
were down-regulated in mesenchyme exhibit Tropomyosin expression, indicative of 
premature differentiation. Scale bars: 100µm. (B’ and C’) Higher magnification of boxed 
regions in (B,C). Scale bars: 50µm. (D-K’) zfh1/ZEB expression is up-regulated in ap> 
EGFR-psqRNAi tumors. Expression of zfh1-long (D-E’) and zfh1-short (G-H’) isoforms in 
wild type and ap> EGFR-psqRNAi tumor mesenchymal cells. Scale bars: 50µm. zfh1-long 
(F) and zfh1-short (I) mRNA expression level measured by quantitative RT-PCR from wild 
type or ap>EGFR-psqRNAi tumors wing discs (n=3 independent experiments; * p<0.05, 
unpaired Student’s t-test. Error bars represent s.e.m. (J-K) Zfh1-shortsfGFP (Green) 
expression is undetected in wildtype (J) but is present in mesenchyme of ap>EGFR-
psqRNAi tumors (K). Zfh1, Magenta, marks mesenchyme; scale bars: 50µm.  
	
 
Genotypes Additional information 
ap > mCD8-GFP y w; Ap-Gal4 / UAS-mCD8-GFP 
ap > EGFR-psq
RNAi
 y w; Ap-Gal4, UAS-psq
RNAi




y w; Ap-Gal4, UAS-psq
RNAi 






y w; Ap-Gal4, UAS-psq
RNAi 




; m6-GFP y w; Ap-Gal4, UAS-psq
RNAi 







y w; Ap-Gal4, UAS-psq
RNAi 









y w; Ap-Gal4, UAS-psq
RNAi 






 ;  Enh3-GFP 
y w; Ap-Gal4, UAS-psq
RNAi 








y w; Ap-Gal4, UAS-psq
RNAi 






; Him-GFP y w; Ap-Gal4, UAS-psq
RNAi 












y w; Ap-Gal4, UAS-psq
RNAi 
/ MHC-LacZ; UAS-EGFR, tub-
Gal80ts/+ 





y w; Ap-Gal4, UAS-psq
RNAi 
/ 15B03-LexA; UAS-EGFR, tub-













y w; Ap-Gal4, UAS-psq
RNAi 









y w; Ap-Gal4, UAS-psq
RNAi 










y w; Ap-Gal4, UAS-psq
RNAi 





























Table S2. List of oligonucleotides. Related to STAR methods.  
